Sergeev, Philipp
Helsingin yliopisto
Affiliaatiot
Helsingin yliopisto
Lähde: ORCID
Koulutus
Tutkinnot
University of Helsinki
Julkaisut (6)
Deep Immune Profiling of Multiple Myeloma at Diagnosis and under Lenalidomide Maintenance Therapy
2023
Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones
2023
Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to Melflufen.
2021
Aktiviteetit ja palkinnot (3)
Preclinical Activity of Selective SYK Inhibitors, Entospletinib and Lanraplenib, Alone or Combined with Targeted Agents in Ex Vivo AML Models with Diverse Mutational Backgroundskonferenssiesitelmä2021
A Potential Role of NK Cells and ABCB9 in Modulating the Response to Melflufen in Multiple Myelomakonferenssiesitelmä2022
Single Cell RNA Sequencing Identifies Potential Molecular Indicators of Response to Melflufen in Multiple Myelomakonferenssiesitelmä2021